Outcomes of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with pazopanib after progression on other targeted therapies (TT): A single-institution experience

被引：0
|
作者：
Matrana, Marc Ryan
Shetty, Aditya V.
Atkinson, Bradley J.
Xiao, Lianchun
Corn, Paul G.
Millikan, Randall E.
Jonasch, Eric
Tannir, Nizar M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas Houston, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4615
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Outcomes of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with pazopanib after progression on other targeted therapies (TT): Updated results
    Matrana, Marc Ryan
    Duran, Cihan
    Shetty, Aditya
    Xiao, Lianchun
    Atkinson, Bradley J.
    Corn, Paul G.
    Charnsangavej, Chusilp
    Jonasch, Eric
    Tannir, Nizar M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [2] Metastatic renal cell carcinoma treated with pazopanib after progression on other targeted agents: A single-institution experience
    Matrana, M. R.
    Atkinson, B. J.
    Corn, P. G.
    Jonasch, E.
    Tannir, N. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [3] Outcomes of patients with late relapse metastatic renal cell carcinoma treated with targeted therapies: A single-institution experience.
    Mandalapu, Kemal Kishore
    Matrana, Marc Ryan
    Poosarla, Teja
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [4] Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with pazopanib after disease progression with other targeted therapies
    Matrana, M. R.
    Duran, C.
    Shetty, A.
    Xiao, L.
    Atkinson, B. J.
    Corn, P.
    Pagliaro, L. C.
    Millikan, R. E.
    Charnsangave, C.
    Jonasch, E.
    Tannir, N. M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (15) : 3169 - 3175
  • [5] Targeted therapies (TT) in metastatic renal cell carcinoma (mRCC): An Italian survey of 902 pts.
    Pasini, Felice
    Fraccon, Anna Paola
    Barile, Carmen
    Sacco, Cosimo
    Sava, Teodoro
    Valduga, Francesco
    Basso, Umberto
    Vattemi, Emanuela
    Rosti, Giovanni
    Durante, Emilia
    Nicodemo, Maurizio
    Lo Re, Giovanni
    Cengarle, Rita
    Bertocchi, Paola
    Bernardi, Daniele
    Sartori, Donata
    Donati, Donatella
    Pegoraro, Cristina
    Inno, Alessandro
    Bassan, Franco
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] Lenvatinib (Len) alone or in combination with everolimus (Eve) in heavily pretreated patients (pts) with metastatic renal cell carcinoma (mRCC) after immune checkpoint inhibitors (ICI) and VEGFR-targeted therapies: A single-institution experience
    Wiele, A. J.
    Ross, J.
    Chahoud, J.
    Lim, Z.
    Xiao, L.
    Campbell, M. T.
    Shah, A. Y.
    Saavedra, A. Zurita
    Jonasch, E.
    Tannir, N. M.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 390 - 390
  • [7] Treatment (trx) Modalities After a Front Line Targeted Therapies in Patients (pts) With Metastatic Renal Cell Carcinoma (mRCC)
    Levy, A.
    Menard, J.
    Albiges-Sauvin, L.
    Loriot, Y.
    Massard, C.
    Blesius, A.
    Di Palma, M.
    Fizazi, K.
    Escudier, B.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S521 - S521
  • [8] Efficacy and safety of pazopanib as a subsequent treatment after failure of other targeted agents in patients with metastatic renal cell carcinoma (mRCC).
    Tan, Jiahuai
    Heilbrun, Lance K.
    Fontana, Joseph A.
    Smith, Daryn
    Heath, Elisabeth I.
    Baranowski, Karen
    Vaishampayan, Ulka N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [9] Clinical outcomes according to ethnicity in patients with metastatic renal cell carcinoma (mRCC) treated with VEGF-targeted therapy (TT).
    Bosse, Dominick
    Xie, Wanling
    Wells, Connor
    Lalani, Aly-Khan A.
    Donskov, Frede
    Bent, Alisha
    Sim, Hao-Wen
    Beuselinck, Benoit
    Bamias, Aristotelis
    Porta, Camillo
    Vaishampayan, Ulka N.
    Pal, Sumanta K.
    Agarwal, Neeraj
    Srinivas, Sandy
    Rini, Brian I.
    Alva, Ajjai Shivaram
    Wood, Lori
    Kapoor, Anil
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Outcomes of patients (pts) with metastatic renal cell carcinoma (mRCC) and sarcomatoid dedifferentiation (sRCC) after treatment with immune checkpoint inhibitors (ICI): A single-institution retrospective study.
    Ross, Jeremy Aaron
    McCormick, Barrett Z.
    Gao, Jianjun
    Msaouel, Pavlos
    Campbell, Matthew T.
    Zurita, Amado J.
    Shah, Amishi Yogesh
    Jonasch, Eric
    Matin, Surena F.
    Wood, Christopher G.
    Karam, Jose A.
    Sharma, Padmanee
    Tannir, Nizar M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345